LifeScienceXchange

LifeScienceXchange offers actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format. LifeScienceXchange multiplies the impact of biologics and immunotherapy R&D, bringing new treatments to patients faster.

Editor's Top Picks

Market Insight

Empowering Peptide Science with Open Source Tools

Rodrigo Ochoa Senior Scientist, Novo Nordisk

Market Insight

FORCE: Delivering Oligos to Beat Rare Muscular Diseases

Timothy Weeden Executive Director, Head of Platform Development, Dyne Therapeutics

Market Insight

Cracking the Solid Tumour Code with CAR T Cells

John Maher Chief Scientific Officer, Leucid Bio

Market Insight

Leveraging Neoantigens for Personalised Cancer Vaccines

Daniela Kleine-Kohlbrecher Senior Project Manager, Evaxion

Technology Spotlight

Revolutionizing Antibody Discovery: Machine Learning and Bioinformatics at Work

Kris Modig Field Application Scientist, PipeBio

Antibody Case Study Banner

Latest Technology Spotlights

Accelerate Your Biologics Design with Computational Modelling Tools

Venturing Beyond Monoclonal Antibodies with GenScript

Boosting Immunotherapy Success with Fun Ways to Bridge Preclinical and Clinical Worlds

NeXT Personal: An Ultra-Sensitive MRD Liquid Biopsy for Early Stage Cancer Recurrence Detection

Latest News

Designing the Future: AI Meets Antibody Engineering

Lung-Targeted Delivery System for Gene Therapies Treats Cancer and Cystic Fibrosis

UCB Plans $5 Billion Manufacturing Investment to Boost Biologics Capacity

Thought Leadership

Smart Molecules: Harnessing AI and Data to Advance Antibody & Protein Engineering

Thomas Kraft Principal Scientist, Roche

Rahmad Akbar Senior Data Scientist in Antibody Design, Novo Nordsik

Esmaiel Jabbari Professor, University of South Carolina

Talip Ucar Senior Director, AstraZeneca

Computational Methods in Structure Based Biologics Engineering

Leonardo De Maria Principal Scientist, AstraZeneca

Origène Nyanguile Professor, University of Applied Sciences Western Switzerland

Clinical Landscape of Multi-Specific Antibodies

Laura von Schantz Chief Technology Officer, Alligator Bioscience

Barbara Hebeis Director of Bioassay Development, AstraZeneca

01JSHBG9AFXJKCQJJEVN9Y4M8D

Market Insight: Across Modalities

Preclinical Development of STING-Agonist Small Molecule Cancer Therapies

TACAs: Opening up the Target Space to a New Frontier

Challenges and Solutions in the Purification of Oligonucleotides

Protein Corona and Freeze-Thaw Stability in Lipid Nanoparticles

The Allosteric Way: Safer & More Effective Next-Gen Small Molecules

Alphamers: A Novel Immunotherapy Platform

Snakebite Medicines: Venom Derived Peptides for Therapeutic Indications

AI-Powered Peptide Design: Transforming Drug Discovery with Machine Learning

Cell-Free Cancer Vaccines Developed in Two Weeks

Potency Testing in RNA Therapeutics